StockNews.com started coverage on shares of Oxbridge Re (NASDAQ:OXBR – Free Report) in a research report sent to investors on Wednesday morning. The firm issued a hold rating on the insurance provider’s stock.
Oxbridge Re Stock Down 3.0 %
OXBR opened at $3.85 on Wednesday. Oxbridge Re has a twelve month low of $0.87 and a twelve month high of $4.96. The company has a market cap of $23.24 million, a PE ratio of -4.58 and a beta of 0.93. The company has a 50-day moving average price of $3.44 and a 200 day moving average price of $2.86.
Institutional Investors Weigh In On Oxbridge Re
An institutional investor recently raised its position in Oxbridge Re stock. Geode Capital Management LLC boosted its stake in Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) by 3.3% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 129,294 shares of the insurance provider’s stock after purchasing an additional 4,141 shares during the period. Geode Capital Management LLC owned about 2.14% of Oxbridge Re worth $359,000 at the end of the most recent quarter. 5.64% of the stock is currently owned by hedge funds and other institutional investors.
About Oxbridge Re
Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology.
Featured Articles
- Five stocks we like better than Oxbridge Re
- EV Stocks and How to Profit from Them
- 3 Promising Penny Stocks to Watch for Long-Term Gains in 2025
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- The 3 Kings of Buybacks in 2024: Can They Do It Again?
- 10 Best Airline Stocks to Buy
- Breaking the Mold: 3 Non-Tech Stocks Ready to Surge in 2025
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.